Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Alimentary Pharmacology & Therapeutics (Suppl) Année : 2015

Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease

Dates et versions

hal-01681028 , version 1 (11-01-2018)

Identifiants

Citer

S. Paul, X. Roblin, L. Peyrin-Biroulet. Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics (Suppl), 2015, 42 (7), pp.939 - 940. ⟨10.1111/apt.13335⟩. ⟨hal-01681028⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More